Trial NCT01859637

View at ClinicalTrials.gov 
Org. Study IDs: EP06-401

Last trial update was posted on 2016-03-28

MeSH Interventions

Lenograstim

MeSH Conditions

Neutropenia

Other Conditions

Severe Chronic Neutropenia

Stopping Reasons

Additional pharmacovigilance activity was considered as fulfilled by the EMA.

Limitations And Caveats

This was an Additional Pharmacovigilance Activity (MEA005). Based on interim study data, complemented with clinical data from continued global development & extensive post-marketing experience MEA005 was considered fulfilled and the study terminated.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID